Neogen Corp Financials
Neogen Corp (NEOG) reported $870.4M in revenue for fiscal year 2026, down 2.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Neogen’s dominant mechanic is high depreciation: cash generation has recovered before reported operating profit fully does.
In the latest year, positive EBITDA of$94.7M coexisted with an operating loss of-$21.6M , showing heavy depreciation and amortization still suppresses reported operating profit after underlying earnings recovered. The near-breakeven net loss of-$7.9M alongside operating cash flow of$83.2M confirms accounting earnings understated cash produced and that cash generation was not dependent on reported net income.
The gross-margin structure remained around
The cash-conversion improvement was helped by lower reinvestment: free cash flow moved from
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Neogen Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Neogen Corp has an operating margin of -2.5%, meaning the company loses $2 on every $100 of revenue. This results in a profitability score of 13/100. This is up from -118.6% the prior year.
Neogen Corp's revenue declined 2.7% year-over-year, from $894.7M to $870.4M. This contraction results in a growth score of 22/100.
Neogen Corp has elevated debt relative to equity (D/E of 0.38), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 8/100, reflecting increased financial risk.
With a current ratio of 3.82, Neogen Corp holds $3.82 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 85/100.
Neogen Corp's free cash flow margin of 3.7% results in a low score of 26/100. Capital expenditures of $51.3M absorb a large share of operating cash flow.
Neogen Corp posts a -0.4% return on equity (ROE), meaning it loses less than $1 for every $100 of shareholders' equity. This results in a returns score of 19/100. This is up from -52.7% the prior year.
Neogen Corp scores 1.39, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($2.6B) relative to total liabilities ($1.3B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Neogen Corp passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Neogen Corp reported a net loss of $7.9M while generating $83.2M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Neogen Corp reported an operating loss of $21.6M against $24.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Neogen Corp generated $870.4M in revenue in fiscal year 2026. This represents a decrease of 2.7% from the prior year.
Neogen Corp's EBITDA was $94.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 110.1% from the prior year.
Neogen Corp reported -$7.9M in net income in fiscal year 2026. This represents an increase of 99.3% from the prior year.
Neogen Corp earned -$0.04 per diluted share (EPS) in fiscal year 2026. This represents an increase of 99.2% from the prior year.
Cash & Balance Sheet
Neogen Corp generated $31.9M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 168.8% from the prior year.
Neogen Corp held $185.5M in cash against $793.7M in long-term debt as of fiscal year 2026.
Not reported for fiscal year 2026.
Margins & Returns
Neogen Corp's gross margin was 46.9% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.2 percentage points from the prior year.
Neogen Corp's operating margin was -2.5% in fiscal year 2026, reflecting core business profitability. No change is given against fiscal year 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Neogen Corp's net profit margin was -0.9% in fiscal year 2026, showing the share of revenue converted to profit. No change is given against fiscal year 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Neogen Corp's ROE was -0.4% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 52.3 percentage points from the prior year.
Capital Allocation
Neogen Corp invested $18.4M in research and development in fiscal year 2026. This represents a decrease of 12.8% from the prior year.
Neogen Corp invested $51.3M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 51.0% from the prior year.
Not reported for fiscal year 2026.
NEOG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $870.4M-2.7% | $894.7M-3.2% | $924.2M+12.4% | $822.4M+56.0% | $527.2M+12.5% | $468.5M+12.0% | $418.2M+1.0% | $414.2M+4.1% | $397.9M+11.1% | $358.3M+11.5% | $321.3M+13.5% | $283.1M+14.4% | $247.4M+19.2% | $207.5M+12.8% | $184.0M |
| Cost of Revenue | $461.9M-2.4% | $473.3M+2.8% | $460.3M+10.5% | $416.5M+46.6% | $284.1M+12.1% | $253.4M+14.2% | $221.9M-0.2% | $222.3M+5.0% | $211.7M+11.8% | $189.4M+12.6% | $168.2M+17.3% | $143.4M+14.9% | $124.8M+27.3% | $98.0M+7.0% | $91.6M |
| Gross Profit | $408.5M-3.1% | $421.4M-9.2% | $463.9M+14.3% | $406.0M+67.1% | $243.0M+13.0% | $215.1M+9.6% | $196.3M+2.3% | $191.9M+3.0% | $186.3M+10.3% | $168.9M+10.4% | $153.1M+9.6% | $139.7M+13.9% | $122.6M+12.0% | $109.5M+18.5% | $92.4M |
| R&D Expenses | $18.4M-12.8% | $21.1M-6.2% | $22.5M-13.6% | $26.0M+52.7% | $17.0M+4.9% | $16.2M+10.1% | $14.8M+15.2% | $12.8M+18.0% | $10.9M+4.5% | $10.4M+5.0% | $9.9M+3.3% | $9.6M+15.0% | $8.3M+7.0% | $7.8M+17.3% | $6.6M |
| SG&A Expenses | $245.1M+12.3% | $218.2M+9.2% | $199.9M-0.6% | $201.2M+143.1% | $82.7M+61.6% | $51.2M+15.5% | $44.3M+8.7% | $40.8M+6.5% | $38.3M+11.9% | $34.2M+17.2% | $29.2M+15.7% | $25.2M+3.2% | $24.4M+20.9% | $20.2M+18.8% | $17.0M |
| Operating Income | -$21.6M+98.0% | -$1.1B-1910.6% | $58.6M+56.2% | $37.5M-36.0% | $58.6M-21.0% | $74.2M+9.8% | $67.5M-0.8% | $68.1M-3.0% | $70.2M+8.1% | $64.9M+15.2% | $56.4M+6.2% | $53.1M+22.4% | $43.4M+6.6% | $40.7M+20.6% | $33.7M |
| Interest Expense | $24.1M-36.7% | $38.1M-9.6% | $42.2M+54.7% | $27.3M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | -$1.1M+97.3% | -$41.1M-738.8% | -$4.9M-691.8% | $828K-93.0% | $11.9M-17.3% | $14.4M+12.1% | $12.8M+0.4% | $12.8M+24.7% | $10.3M-54.8% | $22.7M+19.6% | $19.0M+2.6% | $18.5M+23.3% | $15.0M+6.4% | $14.1M+23.1% | $11.4M |
| Net Income | -$7.9M+99.3% | -$1.1B-11517.0% | -$9.4M+58.9% | -$22.9M-147.3% | $48.3M-20.7% | $60.9M+2.4% | $59.5M-1.2% | $60.2M-4.7% | $63.1M+44.2% | $43.8M+19.8% | $36.6M+9.1% | $33.5M+19.1% | $28.2M+3.6% | $27.2M+20.8% | $22.5M |
| EPS (Diluted) | -$0.04+99.2% | -$5.03-12475.0% | -$0.04+66.7% | -$0.12 | $0.45-21.1% | $0.57 | $0.56-1.8% | $0.57 | $1.21+40.7% | $0.86+19.4% | $0.72-20.0% | $0.90+18.4% | $0.76+1.3% | $0.75+21.0% | $0.62 |
NEOG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.3B-2.8% | $3.4B-24.3% | $4.5B-0.1% | $4.6B+358.7% | $992.9M+7.9% | $920.2M+15.4% | $797.2M+14.6% | $695.7M+12.6% | $618.0M+17.0% | $528.4M+17.4% | $449.9M+14.7% | $392.2M+13.6% | $345.3M+18.8% | $290.6M+15.5% | $251.6M |
| Current Assets | $604.6M+4.8% | $576.9M-2.1% | $589.2M+0.6% | $585.9M-6.5% | $626.8M+6.0% | $591.5M+10.1% | $537.4M+19.5% | $449.5M+19.6% | $375.8M+28.3% | $293.0M+18.0% | $248.2M+7.4% | $231.2M+22.5% | $188.7M+12.1% | $168.4M+17.0% | $143.9M |
| Cash & Equivalents | $185.5M+43.8% | $129.0M-24.4% | $170.6M+4.5% | $163.2M+267.1% | $44.5M-41.2% | $75.6M+14.1% | $66.3M+59.0% | $41.7M-49.8% | $83.1M+7.1% | $77.6M+40.4% | $55.3M-16.4% | $66.1M+62.4% | $40.7M-18.7% | $50.0M+2.0% | $49.0M |
| Inventory | $144.3M-24.4% | $190.8M+0.8% | $189.3M+41.4% | $133.8M+9.4% | $122.3M+21.5% | $100.7M+5.9% | $95.1M+10.5% | $86.0M+13.1% | $76.0M+3.9% | $73.1M+13.6% | $64.4M+24.7% | $51.6M+0.8% | $51.2M+33.6% | $38.3M+9.5% | $35.0M |
| Accounts Receivable | $146.8M-4.3% | $153.4M-11.3% | $173.0M+12.9% | $153.3M+53.8% | $99.7M+8.6% | $91.8M+8.4% | $84.7M+2.5% | $82.6M+4.4% | $79.1M+15.3% | $68.6M+1.4% | $67.7M+14.3% | $59.2M+14.1% | $51.9M+34.0% | $38.7M+8.7% | $35.7M |
| Goodwill | $1.0B-1.7% | $1.1B-50.1% | $2.1B-0.1% | $2.1B+1397.9% | $142.7M+8.5% | $131.5M+19.2% | $110.3M+6.5% | $103.6M+4.1% | $99.6M-5.0% | $104.8M+18.4% | $88.5M+26.2% | $70.1M+2.8% | $68.2M+14.6% | $59.5M+12.1% | $53.1M |
| Total Liabilities | $1.3B-8.7% | $1.4B-2.3% | $1.4B-1.1% | $1.4B+1245.5% | $105.6M+32.2% | $79.8M+10.8% | $72.0M+24.5% | $57.8M0.0% | $57.8M+2.1% | $56.7M+23.8% | $45.8M+11.1% | $41.2M+5.7% | $39.0M+20.9% | $32.3M-0.8% | $32.5M |
| Current Liabilities | $158.2M-9.1% | $174.0M+12.8% | $154.3M+6.1% | $145.5M+86.9% | $77.8M+45.2% | $53.6M+10.5% | $48.5M+26.8% | $38.3M-1.1% | $38.7M+7.5% | $36.0M+25.9% | $28.6M+12.3% | $25.5M+2.0% | $25.0M+40.9% | $17.7M-11.3% | $20.0M |
| Long-Term Debt | $793.7M-9.3% | $874.8M-1.5% | $888.4M+0.3% | $885.4M | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $2.1B+1.0% | $2.1B-34.1% | $3.1B+0.3% | $3.1B+253.2% | $887.4M+5.6% | $840.4M+15.9% | $725.2M+13.7% | $637.9M+13.9% | $560.2M+18.8% | $471.6M+16.7% | $404.2M+15.2% | $351.0M+14.6% | $306.4M+18.6% | $258.2M+18.0% | $218.8M |
| Retained Earnings | -$544.3M-1.5% | -$536.4M-196.5% | $555.6M-1.7% | $565.0M-3.9% | $587.9M+9.0% | $539.6M+12.7% | $478.7M+14.2% | $419.2M+16.8% | $359.1M+21.3% | $295.9M+17.4% | $252.1M+17.0% | $215.6M+18.4% | $182.0M+18.3% | $153.9M+21.5% | $126.7M |
NEOG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $83.2M+43.0% | $58.2M+64.9% | $35.3M-14.0% | $41.0M-39.7% | $68.0M-16.1% | $81.1M-5.6% | $85.9M+34.5% | $63.8M-7.7% | $69.1M+14.7% | $60.3M+70.6% | $35.3M-19.3% | $43.8M+102.1% | $21.7M-18.4% | $26.6M+19.2% | $22.3M |
| Capital Expenditures | $51.3M-51.0% | $104.6M-6.1% | $111.4M+69.4% | $65.8M+169.2% | $24.4M-8.5% | $26.7M+11.1% | $24.1M+64.1% | $14.7M-30.0% | $20.9M+43.7% | $14.6M+2.5% | $14.2M+47.9% | $9.6M-16.7% | $11.5M+29.7% | $8.9M+493.1% | $1.5M |
| Free Cash Flow | $31.9M+168.8% | -$46.4M+39.0% | -$76.1M-207.7% | -$24.7M-156.7% | $43.6M-19.8% | $54.4M-12.0% | $61.8M+25.7% | $49.2M+2.1% | $48.2M+5.4% | $45.7M+116.5% | $21.1M-38.2% | $34.2M+237.5% | $10.1M-42.7% | $17.7M-15.0% | $20.8M |
| Investing Cash Flow | $70.5M+171.1% | -$99.2M-238.6% | -$29.3M-114.6% | $201.0M+306.8% | -$97.2M+7.9% | -$105.6M-18.9% | -$88.8M+25.5% | -$119.1M-43.4% | -$83.1M-33.7% | -$62.1M-1.6% | -$61.1M | N/A | -$51.3M-35.1% | -$38.0M-140.4% | -$15.8M |
| Financing Cash Flow | -$99.4M-6112.5% | -$1.6M-184.2% | $1.9M+101.6% | -$118.1M-1833.2% | $6.8M-79.7% | $33.5M+14.1% | $29.4M+111.6% | $13.9M-39.1% | $22.8M-8.9% | $25.1M+63.8% | $15.3M | N/A | $19.6M+57.0% | $12.5M+81.7% | $6.9M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $3.1M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
NEOG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.9%-0.2pp | 47.1%-3.1pp | 50.2%+0.8pp | 49.4%+3.3pp | 46.1%+0.2pp | 45.9%-1.0pp | 46.9%+0.6pp | 46.3%-0.5pp | 46.8%-0.3pp | 47.1%-0.5pp | 47.6%-1.7pp | 49.4%-0.2pp | 49.5%-3.2pp | 52.8%+2.5pp | 50.2% |
| Operating Margin | -2.5% | -118.6% | 6.3%+1.8pp | 4.6%-6.6pp | 11.1%-4.7pp | 15.8%-0.3pp | 16.2%-0.3pp | 16.4%-1.2pp | 17.6%-0.5pp | 18.1%+0.6pp | 17.5%-1.2pp | 18.8%+1.2pp | 17.5%-2.1pp | 19.6%+1.3pp | 18.3% |
| Net Margin | -0.9% | -122.0% | -1.0%+1.8pp | -2.8%-11.9pp | 9.2%-3.8pp | 13.0%-1.2pp | 14.2%-0.3pp | 14.5%-1.3pp | 15.9%+3.7pp | 12.2%+0.8pp | 11.4%-0.5pp | 11.8%+0.5pp | 11.4%-1.7pp | 13.1%+0.9pp | 12.2% |
| Return on Equity | -0.4%+52.3pp | -52.7%-52.4pp | -0.3%+0.4pp | -0.7%-6.2pp | 5.4%-1.8pp | 7.2%-1.0pp | 8.2%-1.2pp | 9.4%-1.8pp | 11.3%+2.0pp | 9.3%+0.2pp | 9.0%-0.5pp | 9.6%+0.4pp | 9.2%-1.3pp | 10.5%+0.2pp | 10.3% |
| Return on Assets | -0.2%+31.5pp | -31.7%-31.5pp | -0.2%+0.3pp | -0.5%-5.4pp | 4.9%-1.7pp | 6.6%-0.8pp | 7.5%-1.2pp | 8.6%-1.6pp | 10.2%+1.9pp | 8.3%+0.2pp | 8.1%-0.4pp | 8.6%+0.4pp | 8.2%-1.2pp | 9.4%+0.4pp | 8.9% |
| Current Ratio | 3.82+0.5x | 3.32-0.5x | 3.82-0.2x | 4.03-4.0x | 8.05-3.0x | 11.030.0x | 11.08-0.7x | 11.75+2.0x | 9.71+1.6x | 8.14-0.5x | 8.68-0.4x | 9.08+1.5x | 7.56-1.9x | 9.51+2.3x | 7.20 |
| Debt-to-Equity | 0.380.0x | 0.42+0.1x | 0.280.0x | 0.28+0.3x | 0.00-0.1x | 0.100.0x | 0.100.0x | 0.090.0x | 0.100.0x | 0.120.0x | 0.110.0x | 0.120.0x | 0.130.0x | 0.130.0x | 0.15 |
| FCF Margin | 3.7%+8.8pp | -5.2%+3.0pp | -8.2%-5.2pp | -3.0%-11.3pp | 8.3%-3.3pp | 11.6%-3.2pp | 14.8%+2.9pp | 11.9%-0.2pp | 12.1%-0.6pp | 12.8%+6.2pp | 6.6%-5.5pp | 12.1%+8.0pp | 4.1%-4.4pp | 8.5%-2.8pp | 11.3% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Where Neogen Corp Ranks
Frequently Asked Questions
What is Neogen Corp's annual revenue?
Neogen Corp (NEOG) reported $870.4M in total revenue for fiscal year 2026. This represents a -2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Neogen Corp's revenue growing?
Neogen Corp (NEOG) revenue declined by 2.7% year-over-year, from $894.7M to $870.4M in fiscal year 2026.
Is Neogen Corp profitable?
No, Neogen Corp (NEOG) reported a net income of -$7.9M in fiscal year 2026, with a net profit margin of -0.9%.
What is Neogen Corp's EBITDA?
Neogen Corp (NEOG) had EBITDA of $94.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Neogen Corp have?
As of fiscal year 2026, Neogen Corp (NEOG) had $185.5M in cash and equivalents against $793.7M in long-term debt.
What is Neogen Corp's gross margin?
Neogen Corp (NEOG) had a gross margin of 46.9% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Neogen Corp's operating margin?
Neogen Corp (NEOG) had an operating margin of -2.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Neogen Corp's net profit margin?
Neogen Corp (NEOG) had a net profit margin of -0.9% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Neogen Corp's return on equity (ROE)?
Neogen Corp (NEOG) has a return on equity of -0.4% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Neogen Corp's free cash flow?
Neogen Corp (NEOG) generated $31.9M in free cash flow during fiscal year 2026. This represents a 168.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Neogen Corp's operating cash flow?
Neogen Corp (NEOG) generated $83.2M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Neogen Corp's total assets?
Neogen Corp (NEOG) had $3.3B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Neogen Corp's capital expenditures?
Neogen Corp (NEOG) invested $51.3M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Neogen Corp spend on research and development?
Neogen Corp (NEOG) invested $18.4M in research and development during fiscal year 2026.
What is Neogen Corp's current ratio?
Neogen Corp (NEOG) had a current ratio of 3.82 as of fiscal year 2026, which is generally considered healthy.
What is Neogen Corp's debt-to-equity ratio?
Neogen Corp (NEOG) had a debt-to-equity ratio of 0.38 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Neogen Corp's return on assets (ROA)?
Neogen Corp (NEOG) had a return on assets of -0.2% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Neogen Corp's Altman Z-Score?
Neogen Corp (NEOG) has an Altman Z-Score of 1.39, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Neogen Corp's Piotroski F-Score?
Neogen Corp (NEOG) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Neogen Corp's earnings high quality?
Neogen Corp (NEOG) reported a net loss of $7.9M while generating $83.2M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Neogen Corp cover its interest payments?
Neogen Corp (NEOG) reported an operating loss of $21.6M against $24.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Neogen Corp?
Neogen Corp (NEOG) scores 29 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.